Emissary Technology Key to Enrolling First Patient Within 7 Days of FDA Approval of a Dialysis Graft Trial

Emissary Inc. has been selected by Novoste Corporation (Nasdaq:NOVT) to collaborate on monitoring and clinical trial management of Novoste's BRAVO (Beta Radiation for treatment of Arterial-Venous graft Outflow) clinical trial.

Nike Sneakers StoreAir Jordan 1 Low GS Ice Cream Drip CW7104-601 Release Date Info

Read more: Emissary Technology Key to Enrolling First Patient Within 7 Days of FDA Approval of a Dialysis...

Emissary Key to Radiation Study Success

Looking to increase the efficiency of its recently approved beta radiation trial, Novoste (Norcross, Georgia) selected contract research organization Emissary (Austin, Texas) to run the show. Emissary's TeamTrials electronic data capture technology will be used to monitor and manage the BRAVO (Beta Radiation for treatment of Arterial-Venous dialysis graft Outflow) clinical trial.

best Running shoes brandGucci x The North Face Release Information

Read more: Emissary Key to Radiation Study Success

  • Default
  • Title
  • Date
  • Random
load more hold SHIFT key to load all load all